Markets:

Overview

News

Currencies

International

Treasuries

Altimmune, Inc. - Common Stock (NQ:ALT)

4.530 -0.040 (-0.88%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Altimmune, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 26, 2024

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.

Via Benzinga

Stocks Start Week On A Hesitant Note ↗

February 26, 2024

Stocks are barely moving to start the week, just one session removed from record highs.

Via Talk Markets

Biotech Stocks Madrigal, Altimmune In A Tizzy As New Weight-Loss Rival Enters The Arena ↗

February 26, 2024

The results from Boehringer Ingelheim and Zealand Pharma bolstered some biotech stocks. But not all got the same boost.

Via Investor's Business Daily

(ALT) - Analyzing Altimmune's Short Interest ↗

February 14, 2024

Via Benzinga

How Is The Market Feeling About Altimmune? ↗

January 26, 2024

Via Benzinga

$1000 Invested In Altimmune 5 Years Ago Would Be Worth This Much Today ↗

December 08, 2023

Via Benzinga

Altimmune Stock Surges, Kerrisdale Remains Short: What You Need To Know ↗

February 26, 2024

Altimmune shares are trading higher Monday despite a lack of company-specific news. Kerrisdale Capital told Benzinga on Monday that the firm is still short Altimmune stock.

Via Benzinga

TEVA Stock Pops 4% as Teva Receives FDA Approval ↗

February 26, 2024

Teva Pharmaceutical stock is rising higher on Monday after partner company Alvotech got approval from the FDA for a Humira biosimilar.

Via InvestorPlace

Why Is Altimmune (ALT) Stock Up 14% Today? ↗

February 26, 2024

Altimmune stock is rising higher on Monday as ALT investors react to positive news from rival weight loss drugmaker Zealand Pharma.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 26, 2024

Via Benzinga

3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 ↗

February 22, 2024

With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year.

Via InvestorPlace

Kerrisdale Capital Slams Altimmune (ALT) Stock in New Short Report ↗

February 13, 2024

Kerrisdale Capital has released a short report, making clear why it is betting against ALT stock. Here's why Altimmune is likely in trouble.

Via InvestorPlace

Altimmune Stock Sinks As Kerrisdale Capital Announces Short Position: 'Obvious Dead End' ↗

February 13, 2024

Altimmune shares are trading lower Tuesday after short-selling investment firm Kerrisdale Capital published a new research report on the stock and announced a short position

Via Benzinga

Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 13, 2024

Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.

Via Benzinga

Jim Cramer Calls Affirm 'A Winner,' But Not C3.ai: 'I Can't Recommend A Stock With No Earnings' ↗

February 13, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vertiv Holdings Co (NYSE: VRT) is "one of the great per

Via Benzinga

Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs ↗

January 25, 2024

The best weight-loss drug stocks firms improving the drugs or developing new, potentially superior weight-loss treatments.

Via InvestorPlace

Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance ↗

January 11, 2024

Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positioning themselves to tap into the

Via Benzinga

The 3 Best Biotech Stocks to Buy in January 2024 ↗

January 09, 2024

Biotech is still one of the most exciting investments on the market, creating substantial opportunities for some of the best biotech stocks.

Via InvestorPlace

Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

January 08, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 150 points on Monday. Shares of Harpoon Therapeutics, Inc.(NASDAQ: HARP) rose sharply in pre-market trading....

Via Benzinga

Topics Stocks

What's Going On With Obesity Drug-Developer Altimmune Inc Stock? ↗

January 04, 2024

Altimmune, Inc. (NASDAQ: ALT) shares are trading higher Thursday, and the stock has gained more than 140% over the past month.

Via Benzinga

Coherus BioSciences And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

December 27, 2023

U.S. stock futures were slightly lower this morning, with the Dow Jones futures falling around 5 points on Wednesday.

Via Benzinga

Topics Stocks

Gracell Biotechnologies, Stratasys, Hollysys Automation Technologies And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗

December 26, 2023

U.S. stock futures were higher this morning, with the Dow Jones futures gaining more than 40 points on Tuesday.

Via Benzinga

Topics Stocks

Russell 2000 Rallies To 16-Month Highs: Best Performing Small-Cap Stocks Popping Over 80% In December ↗

December 19, 2023

Amidst fanfare for Nasdaq 100, U.S. small-cap stocks rally, with Russell 2000 index reaching levels not seen since Aug. 2022, 80% of stocks trading above 50-day MA, outperforming large caps &...

Via Benzinga

Topics ETFs

Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them' ↗

December 08, 2023

A hearing from the Senate led by Bernie Sanders will look at diabetes and the rise of weight loss drugs.

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

December 08, 2023

A weekly look at top trending tickers seeing increased attention from Benzinga users.

Via Benzinga

Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday ↗

December 07, 2023

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining more than 100 points on Thursday.

Via Benzinga

Topics Stocks

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

December 06, 2023

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.

Via Benzinga

Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 07, 2023

Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 06, 2023

Via Benzinga

JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities ↗

December 06, 2023

Johnson & Johnson (NYSE: JNJ) has no immediate plans to venture into weight-loss drugs due to the existing competition saturation, as Chief Executive Officer

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Altimmune, Inc. - Common Stock (NQ:ALT)

Headline News about Altimmune, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today